Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

AstraZeneca, Pfizer-BioNTech's COVID-19 Jabs Work Well With Moderna Shot, UK Study Says

12/06/2021 | 10:32pm EST


ę MT Newswires 2021
All news about PFIZER, INC.
10:22aEU regulator recommends Pfizer's COVID pill be authorized
AQ
09:44aEuropean Medicines Agency Recommends Pfizer's COVID-19 Antiviral Pill
MT
09:17aPfizer Receives CHMP Positive Opinion for Novel COVID-19 Oral Treatment
BU
09:14aEU drug regulator OKs Pfizer COVID pill for high-risk patients
RE
09:07aEMA green lights Pfizer's COVID-19 pill
RE
09:03aPFIZER'S COVID-19 PILL GETS POSITIVE : Bloomberg
MT
01:21aPfizer tests omicron vaccine in humans
AQ
01/27PFIZER, INC. : Ex-dividend day for
FA
01/26Pfizer-BioNTech, Moderna COVID-19 Jabs Shown Safe For Women Undergoing IVF in Study
MT
01/26Pfizer Seeks Role in US COVID-19 Vaccine Litigation to Protect Trade Secrets
MT
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2021 81 786 M - -
Net income 2021 22 567 M - -
Net Debt 2021 27 401 M - -
P/E ratio 2021 13,9x
Yield 2021 2,99%
Capitalization 298 B 298 B -
EV / Sales 2021 3,97x
EV / Sales 2022 3,03x
Nbr of Employees 78 500
Free-Float 59,3%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Last Close Price 53,01 $
Average target price 57,88 $
Spread / Average Target 9,19%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Susan Silbermann President & General Manager-Pfizer Vaccines
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Executive VP, President-Research & Development
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.-10.23%297 538
JOHNSON & JOHNSON-1.57%443 277
ROCHE HOLDING AG-7.91%306 143
ABBVIE INC.-0.86%237 303
ELI LILLY AND COMPANY-13.89%215 642
NOVO NORDISK A/S-15.89%213 450